$4.20
-0.445[-9.58%]
At close: Apr 25
$4.20
0[0.00%]
After Hours: 6:21PM EDT
Ocular Therapeutix
(NASDAQ:OCUL)Ocular Therapeutix Stock (NASDAQ:OCUL), Analyst Ratings, Price Targets, Predictions
Ocular Therapeutix Inc has a consensus price target of $16.14, established from looking at the 36 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., JMP Securities, and JMP Securities on April 19, 2024, April 16, 2024, and March 13, 2024. With an average price target of $21.33 between HC Wainwright & Co., JMP Securities, and JMP Securities, there's an implied 407.94% upside for Ocular Therapeutix Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
JMP Securities
TD Cowen
Piper Sandler
B of A Securities
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Ocular Therapeutix
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/19/2024 | OCUL | Buy Now | Ocular Therapeutix | $4.20 | 280.95% | HC Wainwright & Co. | Yi Chen | → $16 | Reiterates | Buy → Buy | Get Alert |
| 04/16/2024 | OCUL | Buy Now | Ocular Therapeutix | $4.20 | 471.43% | JMP Securities | Jonathan Wolleben | → $24 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 03/13/2024 | OCUL | Buy Now | Ocular Therapeutix | $4.20 | 471.43% | JMP Securities | Jonathan Wolleben | → $24 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 03/13/2024 | OCUL | Buy Now | Ocular Therapeutix | $4.20 | 257.14% | HC Wainwright & Co. | Yi Chen | $12 → $15 | Maintains | Buy | Get Alert |
| 03/12/2024 | OCUL | Buy Now | Ocular Therapeutix | $4.20 | 161.9% | TD Cowen | Tara Bancroft | $8 → $11 | Maintains | Market Perform | Get Alert |
| 03/12/2024 | OCUL | Buy Now | Ocular Therapeutix | $4.20 | 471.43% | JMP Securities | Jonathan Wolleben | $12 → $24 | Maintains | Market Outperform | Get Alert |
| 02/26/2024 | OCUL | Buy Now | Ocular Therapeutix | $4.20 | 257.14% | Piper Sandler | Joseph Catanzaro | $10 → $15 | Maintains | Overweight | Get Alert |
| 02/14/2024 | OCUL | Buy Now | Ocular Therapeutix | $4.20 | 185.71% | HC Wainwright & Co. | Yi Chen | → $12 | Reiterates | Buy → Buy | Get Alert |
| 02/09/2024 | OCUL | Buy Now | Ocular Therapeutix | $4.20 | 257.14% | B of A Securities | Tazeen Ahmad | → $15 | Initiates | → Buy | Get Alert |
| 10/04/2023 | OCUL | Buy Now | Ocular Therapeutix | $4.20 | 185.71% | HC Wainwright & Co. | Yi Chen | → $12 | Reiterates | Buy → Buy | Get Alert |
| 09/14/2023 | OCUL | Buy Now | Ocular Therapeutix | $4.20 | 328.57% | Baird | Colleen Kusy | → $18 | Reiterates | Outperform → Outperform | Get Alert |
| 08/08/2023 | OCUL | Buy Now | Ocular Therapeutix | $4.20 | 185.71% | HC Wainwright & Co. | Yi Chen | → $12 | Reiterates | Buy → Buy | Get Alert |
| 06/13/2023 | OCUL | Buy Now | Ocular Therapeutix | $4.20 | 185.71% | Baird | Colleen Kusy | $10 → $12 | Maintains | Outperform | Get Alert |
| 06/13/2023 | OCUL | Buy Now | Ocular Therapeutix | $4.20 | 185.71% | JMP Securities | Jonathan Wolleben | → $12 | Reiterates | → Market Outperform | Get Alert |
| 06/13/2023 | OCUL | Buy Now | Ocular Therapeutix | $4.20 | 185.71% | HC Wainwright & Co. | Yi Chen | $10 → $12 | Maintains | Buy | Get Alert |
| 05/09/2023 | OCUL | Buy Now | Ocular Therapeutix | $4.20 | 138.1% | HC Wainwright & Co. | Yi Chen | $11 → $10 | Maintains | Buy | Get Alert |
| 05/09/2023 | OCUL | Buy Now | Ocular Therapeutix | $4.20 | 185.71% | JMP Securities | Jonathan Wolleben | $11 → $12 | Maintains | Outperform | Get Alert |
| 04/21/2023 | OCUL | Buy Now | Ocular Therapeutix | $4.20 | 328.57% | Baird | Colleen Kusy | → $18 | Initiates | → Outperform | Get Alert |
| 03/07/2023 | OCUL | Buy Now | Ocular Therapeutix | $4.20 | 161.9% | HC Wainwright & Co. | Yi Chen | → $11 | Reiterates | → Buy | Get Alert |
FAQ
What is the target price for Ocular Therapeutix (OCUL)?
The latest price target for Ocular Therapeutix (NASDAQ: OCUL) was reported by HC Wainwright & Co. on April 19, 2024. The analyst firm set a price target for $16.00 expecting OCUL to rise to within 12 months (a possible 280.95% upside). 17 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Ocular Therapeutix (OCUL)?
The latest analyst rating for Ocular Therapeutix (NASDAQ: OCUL) was provided by HC Wainwright & Co., and Ocular Therapeutix reiterated their buy rating.
When was the last upgrade for Ocular Therapeutix (OCUL)?
The last upgrade for Ocular Therapeutix Inc happened on August 10, 2021 when HC Wainwright & Co. raised their price target to $17. HC Wainwright & Co. previously had a neutral for Ocular Therapeutix Inc.
When was the last downgrade for Ocular Therapeutix (OCUL)?
There is no last downgrade for Ocular Therapeutix.
When is the next analyst rating going to be posted or updated for Ocular Therapeutix (OCUL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ocular Therapeutix, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ocular Therapeutix was filed on April 19, 2024 so you should expect the next rating to be made available sometime around April 19, 2025.
Is the Analyst Rating Ocular Therapeutix (OCUL) correct?
While ratings are subjective and will change, the latest Ocular Therapeutix (OCUL) rating was a reiterated with a price target of $0.00 to $16.00. The current price Ocular Therapeutix (OCUL) is trading at is $4.20, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.